연구성과로 돌아가기

2024 연구자 정보 (696 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Choi, Han Seok
(Choi, HS)
Dongguk Univ, Ilsan Hosp, Coll Med, Dept Internal Med, Goyang, South Korea AAG-1493-2019
Choi, Han

[JCR상위 27.0] Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations
[JCR상위 27.0] Effects of Endocrine-Disrupting Chemicals on Bone Health
SCIE 27.0 ENDOCRINOLOGY & METABOLISM drbkh@catholic.ac.kr;
kjeun@knu.ac.kr;swkimmd@snu.ac.kr;
Chon, Suk
(Chon, S)
Kyung Hee Univ, Kyung Hee Univ Hosp, Coll Med, Dept Endocrinol & Metab, Seoul, South Korea AAV-3102-2020
Chon, Suk

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Choo, Eunjung
(Choo, E)
Ajou Univ, Res Inst Pharmaceut Sci & Technol RIPST, Suwon, South Korea
Ajou Univ, Coll Pharm, Suwon, South Korea


[JCR상위 27.0] Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study
[JCR상위 18.1] Continuity of primary care and avoidable hospitalization in a young population with asthma: a population-based cohort study
SCIE 18.1 MEDICINE, GENERAL & INTERNAL;MEDICINE, RESEARCH & EXPERIMENTAL
MULTIDISCIPLINARY SCIENCES
hankil@ajou.ac.kr;
leeiynhyang@ynu.ac.kr;jenk@pusan.ac.kr;
Chung, Yoon-Sok
(Chung, YS)
교신저자 Ajou Univ, Sch Med, Dept Endocrinol & Metab, 206 World Cup Ro, Suwon 16499, South Korea
0000-0003-0179-4386
Chung, Yoon-Sok
[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Ha, Jeonghoon
(Ha, J)
Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea
Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Seoul, South Korea
MAI-4246-2025
Ha, Jeonghoon
0000-0001-9219-7135
Ha, Jeonghoon
[JCR상위 27.0] Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations
[JCR상위 27.0] Effects of Endocrine-Disrupting Chemicals on Bone Health
SCIE 27.0 ENDOCRINOLOGY & METABOLISM drbkh@catholic.ac.kr;
kjeun@knu.ac.kr;swkimmd@snu.ac.kr;
Hong, Eun-Gyoung
(Hong, EG)
Hallym Univ, Dongtan Sacred Heart Hosp, Dept Internal Med, Div Endocrinol & Metab, Hwaseong, South Korea

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Hong, Namki
(Hong, N)
Yonsei Univ, Endocrine Res Inst, Coll Med, Dept Internal Med, Seoul, South Korea
Yonsei Univ, Coll Med, Endocrine Res Inst, Dept Internal Med, Seoul, South Korea
AAF-8357-2019
Hong, Namki
0000-0002-8246-1956
Hong, Namki
[JCR상위 27.0] Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations
[JCR상위 27.0] Effects of Endocrine-Disrupting Chemicals on Bone Health
SCIE 27.0 ENDOCRINOLOGY & METABOLISM drbkh@catholic.ac.kr;
kjeun@knu.ac.kr;swkimmd@snu.ac.kr;
Hong, Seongbin
(Hong, SB)
Inha Univ, Coll Med, Dept Endocrinol & Metab, Incheon, South Korea

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Jeong, Chang Wook
(Jeong, CW)
Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea
Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea
Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Urol, Coll Med, Seoul 03080, South Korea
Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea
Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Urol, Seoul, South Korea


[JCR상위 27.0] Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study
[JCR상위 38.5] Machine learning models for predicting the onset of chronic kidney disease after surgery in patients with renal cell carcinoma
[JCR상위 38.0] Optimal sequential therapy using tyrosine kinase inhibitors as the first-line treatment in patients with metastatic renal cell carcinoma: A nationwide multicenter study
[JCR상위 30.8] Oncological Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide with versus without Confirmatory Bone Scan
[JCR상위 25.2] Sites of Metastasis and Survival in Metastatic Renal Cell Carcinoma: Results From the Korean Renal Cancer Study Group Database
[JCR상위 6.2] Comparison of Short-Term Outcomes and Safety Profiles between Androgen Deprivation Therapy plus Abiraterone/Prednisone and Androgen Deprivation Therapy plus Docetaxel in Patients with De Novo Metastatic Hormone-Sensitive Prostate Cancer
SCIE
ESCI
6.2 MEDICINE, GENERAL & INTERNAL;MEDICINE, RESEARCH & EXPERIMENTAL
MEDICAL INFORMATICS
UROLOGY & NEPHROLOGY
ONCOLOGY
MEDICINE, GENERAL & INTERNAL
ANDROLOGY;UROLOGY & NEPHROLOGY
hankil@ajou.ac.kr;
toomey@catholic.ac.kr;
victorjo38@hanyang.ac.kr;
mdrafael@snu.ac.kr;
urohwang@gmail.com;
skhwan.script@gmail.com;
Jeong, In-Kyung
(Jeong, IK)
Kyung Hee Univ, Coll Med, Kyung Hee Univ Hosp Gangdong, Div Rheumatol,Dept Internal Med, Seoul, South Korea C-4195-2018
Choi, Kyung

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Jin, Heung Yong
(Jin, HY)
Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Div Endocrinol & Metab,Dept Internal Med, Res Inst Clin Med,Biomed Res Inst,Med Sch, Jeonju, South Korea

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Joung, Kyong Hye
(Joung, KH)
Chungnam Natl Univ Coll Med, Dept Internal Med, Div Endocrinol & Metab, Daejeon, South Korea

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Kang, Hyunha
(Kang, H)
제1저자 Ajou Univ, Coll Pharm, 206 Worldcup Ro, Suwon 16499, Gyeonggi Do, South Korea

[JCR상위 27.0] Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study SCIE 27.0 MEDICINE, GENERAL & INTERNAL;MEDICINE, RESEARCH & EXPERIMENTAL hankil@ajou.ac.kr;
Kim, Chong Hwa
(Kim, CH)
Bucheon Sejong Hosp, Dept Internal Med, Bucheon, South Korea

[JCR상위 27.0] Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE) SCIE 27.0 ENDOCRINOLOGY & METABOLISM kcwon@med.yu.ac.kr;yschung@ajou.ac.kr;k50367@korea.ac.kr;
Kim, Kyoung Jin
(Kim, KJ)
제1저자 Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea F-2905-2014
Kim, Su-jin
0000-0001-7925-2515
Kim, Kyoung Jin
[JCR상위 27.0] Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations
[JCR상위 27.0] Effects of Endocrine-Disrupting Chemicals on Bone Health
SCIE 27.0 ENDOCRINOLOGY & METABOLISM drbkh@catholic.ac.kr;
kjeun@knu.ac.kr;swkimmd@snu.ac.kr;
페이지 이동: